日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

生物可吸收血管支架与金属药物洗脱支架在再狭窄高风险患者中的比较:COMPARE-ABSORB试验的7年最终结果

Smits, Pieter C; Włodarczak, Adrian; Chevalier, Bernard; West, Nick E J; Gori, Tommaso; Abdel-Wahab, Mohamed; Barbato, Emanuele; Esposito, Giovanni; Tarantini, Giuseppe; Kocka, Viktor; Achenbach, Stephan; Dudek, Dariusz; Escaned, Javier; Tijssen, Jan G P; Rademaker-Havinga, Tessa A M; Serruys, Patrick; Morice, Marie-Claude; Onuma, Yoshinobu; Geuns, Robert-Jan van; Behalf Of The Compare-Absorb Trial Investigators, On

Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism

PRAGUE-26 的设计和原理:一项针对中高危急性肺栓塞的导管溶栓治疗的多中心随机试验

Kroupa, Josef; Radvan, Martin; Mrozek, Jan; Sluka, Martin; Jirous, Stepan; Hlinomaz, Ota; Pliva, Milan; Pudil, Jan; Voberkova, Hana; Kozel, Martin; Poloczek, Martin; Kamenik, Martin; Brabec, Michal; Lichnerova, Eva; Hutyra, Martin; Bernat, Ivo; Novak, Martin; Tousek, Petr; Kocka, Viktor

Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者进行长期随访

Klancik, Viktor; Pesl, Ladislav; Neuberg, Marek; Tousek, Petr; Kocka, Viktor

Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.

TRAIL 与接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的左心室射血分数之间的关系

Teringova Elena, Kozel Martin, Knot Jiri, Kocka Viktor, Benesova Klara, Tousek Petr